Candel Therapeutics CADL 深 滬
等待開盤 09-24 09:30:00 美东时间
11.29
-0.560
-4.73%
華盛通- 最 高12.0056
- 今 開11.93
- 成交量 128.78万股
- 最 低 11.27
- 昨 收 11.85
- 總市值 8.64亿
- 52周最高 14.00
- 市盈率 靜 --
- 換手率 1.68%
- 52周最低 4.35
- 委 比 87.73%
- 總股本 7651.86万
- 歷史最高 14.78
- 量 比 0.93
- 振 幅 6.21%
- 歷史最低 0.66
- 每 手 1
- 風險率 2.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
This Macerich Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI Group analyst Michael Griffin upgraded Macerich Co (NYSE:MAC) from In-Line to Outper...
09-21 20:17
B of A Securities Upgrades Candel Therapeutics to Buy, Raises Price Target to $18
B of A Securities analyst Alec Stranahan upgrades Candel Therapeutics (NASDAQ:CADL) from Neutral to Buy and raises the price target from $12 to $18.
09-21 18:48
Candel Therapeutics Highlights Progress of Lead Oncology Candidate
An announcement from Candel Therapeutics ( ($CADL) ) is now available. In Septe...
09-10 05:17
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics granted stock options to two new employees under its 2025 Inducement Plan, allowing them to purchase 31,400 shares at $13.07 per share. The options vest 25% after one year and the remaining 75% in monthly installments over three years, contingent on continued employment. Candel, a clinical-stage biopharmaceutical company, focuses on developing multimodal immunotherapies for cancer treatment. Its lead product, aglatimagene, has...
09-01 20:05
Candel Therapeutics to Present at September Investor Conferences
Candel Therapeutics announced that its CEO, Paul Peter Tak, will participate in fireside chats and one-on-one meetings at three investor conferences in September 2026. The events include Citi's Biopharma Back to School Conference on September 9, the Cantor Global Healthcare Conference on September 10, and H.C. Wainwright's Global Investment Conference on September 15. Live webcasts and replays will be available on Candel's website. Candel is a cl...
08-26 12:05
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $23 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Candel Therapeutics (NASDAQ:CADL) with a Buy and maintains $23 price target.
08-14 00:06
Candel Therapeutics Q2 EPS $(0.52) Misses $(0.23) Estimate
Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.23) by 126.09 percent. This is a 477.78 percent decrease over losses of $(0.09) per share from the same period last year.
08-13 20:47
